Crossmark

Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response

Crossref DOI link: https://doi.org/10.1007/s10495-022-01723-2

Published Online: 2022-04-02

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gupta, Vishal Kumar

Kumar, Ajay https://orcid.org/0000-0002-6635-0586
Funding

Funding for this research was provided by:

Science and Engineering Research Board (ECR/2016/001117)
License Information

Text and Data Mining valid from 2022-04-02

Version of Record valid from 2022-04-02
More Information

Article History

Accepted: 15 March 2022

First Online: 2 April 2022

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below